Peter H. Andersen

The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action

Peter H. Andersen · European Journal of Pharmacology · 1989 · 347 citations · Full text

Molecular Pharmacology, Biochemistry, G Protein-coupled Receptor +9

Biochemical and Pharmacological Characterization of [³H]GBR 12935 Binding In Vitro to Rat Striatal Membranes: Labeling of the Dopamine Uptake Complex

Peter H. Andersen · Journal of Neurochemistry · 1987 · 231 citations

Pharmacological Characterization, Synaptic Signaling, Molecular Pharmacology +17

<i>(R)‐N</i>‐[4,4‐Bis(3‐Methyl‐2‐Thienyl)but‐3‐en‐1‐yl]Nipecotic Acid Binds with High Affinity to the Brain γ‐Aminobutyric Acid Uptake Carrier

Erik B. Nielsen, Ursula Sonnewald, Lars J. S. Knutsen et al. · Journal of Neurochemistry · 1990 · 228 citations

A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum

Peter H. Andersen, Frederik C. Grønvald, Jens Aas Jansen · Life Sciences · 1985 · 142 citations · Full text

Molecular Pharmacology, Dopamine-stimulated Adenylate Cyclase, Molecular Neuroscience +12

Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain

Peter H. Andersen · European Journal of Pharmacology · 1988 · 110 citations · Full text

Molecular Pharmacology, Pharmacological Characteristics, Functional Selectivity +8